You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

EPLERENONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Eplerenone

A generic version of EPLERENONE was approved as eplerenone by CHARTWELL RX on July 30th, 2008.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for EPLERENONE?
  • What are the global sales for EPLERENONE?
  • What is Average Wholesale Price for EPLERENONE?
Drug patent expirations by year for EPLERENONE
Drug Prices for EPLERENONE

See drug prices for EPLERENONE

Recent Clinical Trials for EPLERENONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityPhase 4
Mario Negri Institute for Pharmacological ResearchPhase 3
Vifor PharmaPhase 3

See all EPLERENONE clinical trials

Pharmacology for EPLERENONE
Drug ClassAldosterone Antagonist
Mechanism of ActionAldosterone Antagonists
Paragraph IV (Patent) Challenges for EPLERENONE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
INSPRA Injection eplerenone 0.75 mg/mL, 100 mL vial 021437 1 2009-06-05
INSPRA Tablets eplerenone 25 mg and 50 mg 021437 2 2006-09-27

US Patents and Regulatory Information for EPLERENONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare EPLERENONE eplerenone TABLET;ORAL 206922-001 Jul 13, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Westminster Pharms EPLERENONE eplerenone TABLET;ORAL 207842-002 Oct 25, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx EPLERENONE eplerenone TABLET;ORAL 078482-001 Jul 30, 2008 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.